Patients will no longer have to travel to Dublin for advanced radiotherapy services. The treatment is now available in Cork, at the Bon Secours hospital’s new Cork Cancer Centre.
The hospital’s €77m expansion, in partnership with a US-based academic medical centre, offers medical, surgical, and radiation oncology.
It is part of an overall development of the Bon Secours Cork hospital that includes four additional operating theatres, a 23-bed day infusion ward, and a critical care unit.
“We are delighted to be partnering with UPMC to offer the most advanced radiotherapy services possible, as part of a one-stop-shop for all critical cancer services patients who need access to screening, diagnosis, and treatment,” Harry Canning, hospital manager at Bon Secours Hospital Cork, said. “Part of the new hospital expansion includes a new critical care unit that will provide highly skilled diagnosis and best-practice treatment to acutely ill patients across all our medical and surgical areas of expertise.
“This is a huge milestone in our drive to deliver advanced medicine and exceptional care to an increasing number of patients across the region.”
The new radiotherapy services will be led by radiation oncologist Paul Kelly. “It’s a real honour for me, as a radiation oncologist, to offer state-of-the-art radiotherapy, including stereotactic technology, to patients in the region for the first time,” Dr Kelly said.
The new radiotherapy service will be provided to patients as part of a joint venture between Bon Secours and the UPMC Hillman Cancer Centre, one of the largest cancer treatment networks in the United States.
Patients will now have access to advanced radiotherapy services previously unavailable in Munster, including stereotactic radiosurgery (SRS), a non-surgical radiation therapy that uses concentrated radiation beams in high doses to destroy tumours in hard-to-reach areas of the body, while minimising damage to surrounding healthy tissues.
Fifty new jobs have also been created with the opening of the Cork Cancer Centre.